Skip to main content
. 2022 Jan 25;10(1):e003747. doi: 10.1136/jitc-2021-003747

Figure 2.

Figure 2

Kaplan-Meier estimates of progression-free (PFS) and overall survival (OS). Kaplan-Meier estimates of (A) PFS and (B) OS of the radioimmunotherapy (RIT) cohort. Kaplan-Meier estimates of (C) PFS and (D) OS of the entire study cohort. Tick marks indicate censored observations.